There have been many reports of the induction of apoptosis by anti-cancer drugs in susceptible cells (reviewed by Hickman, 1992 ; Sen and D'Incalci, 1993; Dive and Wyllie, 1993; Eastman, 1993) . Drugs with very disparate mechanisms of action initiate this conserved cellular response, characterised in plasma membrane-intact cells by a condensation of chromatin and the appearance of higher order chromatin fragments and/or 200 bp integer internucleosomal fragments (Wylie, 1980; Oberhammer et al., 1993) . The initiation of this conserved cellular response suggests that events which are downstream of the immediate actions of the drugs, such as the inhibition of topoisomerase II and induction of DNA double-strand breaks by etoposide, couple either perturbations in cellular metabolism or cellular damage to the engagement of apoptosis (Dive and Hickman, 1991) . The nature of these coupling events is not well defined, nor is it known what shared features, such as changes in gene expression, may be necessary for the initiation of apoptosis by different drugs. It is important that these be understood as it is probable that much of the clinically relevant drug resistance may be the result of cellular attenuation of the apoptotic response to pharmacological perturbations .
It has been proposed recently that deregulated expression of the c-myc oncogene may promote apoptosis in certain cells, including those of myeloid lineage and primary fibroblasts (Askew et al., 1991; Evan et al., 1992) . However, dexamethasone (DEX) was reported to bring about a reduction of c-myc mRNA (Yuh and Thompson, 1989) and protein (Wood et al., 1994) before the apoptosis of the lymphoblastoid cell line CCRF CEM C7A. This suggests that these cells do not die because of the continued expression of c-myc under conditions of pharmacologically imposed limited growth. It was argued, on the basis of experiments using transient transfections of c-myc, that the suppression of expression was necessary for DEX-induced death of these cells (Thulasi et al., 1993) . Measurement of changes in c-myc expression and the kinetics of apoptosis induced by agents with different cellular targets was therefore considered to be of interest. DEX, a transcriptional modulator, has been the subject of a number of studies of the molecular mechanisms of apoptosis and induces a G, block in CCRF lymphoblastic leukaemia cells (Harmon et al., 1979; Wood et al., 1994) ; the kinetics of apoptosis induced by continuous incubation with DEX was characterised by a 36 h lag phase before the onset of apoptosis, which we designated the priming phase (Wood et al., 1994) . Etoposide is a topoisomerase II inhibitor which induces transient DNA double-strand breaks (Liu, 1989) and N-methylformamide (NMF) is a cytotoxin which, like DEX, inhibits passage through the cell cycle at the GI phase (Bill et al., 1988) and is considered to have the plasma membrane as an important locus of action (Dibner et al., 1985) . The results of the present study suggest that apoptosis induced by these three mechanistically disparate agents has certain features in common. However, on the basis of the data it is suggested that changes in the expression of the c-myc proto-oncogene are incidental to drug-induced apoptotic cell death. Materials (1979) . Immunoblotting was performed using the monoclonal mouse-antihuman antibody CTI9 raised to a peptide of the C-terminal end of the c-Myc protein (Evan et al., 1985) . Peroxidase-conjugated secondary antibodies were incubated with the blots for I h before visualising the proteins by use of an enhanced chemiluminescence system (Amersham, UK).
Results
Induction of apoptosis by drugs Concentration-response relationships were established for each agent (data not shown) and a kinetic analysis of cell death was then performed with a drug-concentration-induced maximum apoptosis with minimal loss of membrane integrity. Analysis of DNA integrity by field inversion gel electrophoresis showed the appearance of higher order chromatin fragments (Figure 1 ). typical of apoptosis (Oberhammer et al., 1993) . Figure 2a- Figure 3 . The loss of c-Myc protein preceded the appearance of apoptotic cells in all cases, with kinetics which reflected the order of the time of onset of cell death (see Figure 2 ).
Induction of apoptosis after a priming period Because each of the agents induced apoptosis after a lag phase (Figure 2) , it was of interest to determine whether some of the events which occurred in this phase were common to each agent. If so, it would be predicted that when the initiating stimulus was withdrawn, just before the onset of apoptosis and a different agent added, apoptosis might be initiated without delay. The results are shown in Figure 4 for experiments with NMF and DEX. These two agents were used because their lag phases are very significantly different, whereas we considered that those between etoposide and NMF were similar enough to give rise to potentially equivocal results regarding changes in the timing of the onset of apoptosis. Incubation with DEX for 36 h, followed by washing before the addition of NMF, induced a rapid engagement of apoptosis. It had previously been shown that the removal of DEX at 36 h prevents apoptosis thereafter (Wood et al., 1994) . The prior treatment with DEX therefore circumvented the delay before NMF-induced apoptosis (Figure 4) . However, when the experiment was performed in reverse, with an 8 h NMF preincubation before the addition of DEX (after removal of NMF), an immediate onset of apoptosis was not observed (Figure 4) . Rather, the kinetics of the onset of apoptosis resembled that of DEX alone. Figure 5 . In comparison with our previous study (Wood et al., 1994) , in which cycloheximide inhibited DEX-induced apoptosis, it had no effect on NMF or etoposide-induced cell death.
Dioass
The disparate nature of the triggering events for apoptosis, ranging from trophic factor withdrawal to the imposition of a variety of types of cellular damage, might be expected to be integrated at some point so as to activate conserved processes, such as DNA cleavage, which as effectors commit the cell to an apoptotic death. (Reed, 1994 Thompson, 1989) and protein (Wood et al., 1994) . But, by a variety of experimental manipulations, our data (Wood et al., 1994) did not support the case for a causative role for c-myc suppression in DEX-induced apoptosis, in contradiction to the work of Thulasi et al. (1993) . With respect to the experiments described here, it was interesting that the action of two other drugs was also characterised by a lag phase before the onset of apoptosis (Figure 2) , the length of which was proportional to the rate of disappearance of the c-Myc protein (Figure 3 ). (AC Wood et al., unpublished) . A drug-induced fall in c-myc expression has also been observed as a common event in the treatment of a variety of cells with different agents, including NMF, at concentrations which induce both differentiation and apoptosis (Lachman and Skoultchi, 1984; Yen, 1985; Mitchell et al.,1992; Beere et al., 1993 cells.
The other point to note regarding the c-myc protooncogene is that its continued expression is not necessary for the induction of apoptosis of CCRF CEM C7A cells ( Figure  4 ). This is different from suggestions arising from the work of Evan et al. (1992) 
